Health insurer deal fever may spread to hospitals next
Seeing mergers like Anthem’s planned acquisition of Cigna Corp., hospitals could decide that striking deals of their own could improve their negotiating power over medical reimbursements.
Health Care Businesses
Articles
Lilly posts lackluster profit but boosts full-year forecast
Eli Lilly and Co.’s profits plunged 18 percent in the second-quarter but still easily beat the lowered expectations of Wall Street analysts.
Alzheimer’s trials offer little certainty for investors, patients
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer’s drug.
Study shows Lilly’s Alzheimer’s drug has small but lasting benefit
New data released Wednesday morning suggest that Eli Lilly and Co.’s Alzheimer’s drug has a modest but lasting impact on the memory-sapping disease. But analysts worry the impact is too small to be meaningful.
Indy-based health data firm snares $1.5M in VC round
Healthiest Employers LLC, which collects and measures corporate health information, plans to use the funds to drive sales of its analytics software.
Cook Pharmica to hire 70 workers to expand drug-making capacity
Cook Pharmica, a subsidiary of Bloomington-based medical device maker Cook Group, currently employs 575 workers who manufacture and package drugs for use in clinical trials or for sale on the market.
Lilly partner Immunocore raises record $320 million
Immunocore Ltd., which this week achieved the biggest private fundraising by a European biotechnology firm in 10 years, plans to accelerate development of its cancer therapy using the money and seek expedited approval.
Clot risk in Lilly lung-cancer drug raises FDA concerns
The drug, known as necitumumab, improved patients’ overall chances of survival, yet people taking the medicine also experienced more risk, Food and Drug Administration staff said in a report Tuesday.
Aetna agrees to buy Humana in $37B deal
Aetna Inc. agreed to buy Humana Inc., the second-largest provider of private Medicare insurance, for $37 billion in cash and stock to broaden its health-care coverage.
Community Health to pay $20M to settle false claims charges
The Indianapolis-based hospital system has agreed to pay $20.3 million to settle claims that it overbilled the Medicare and Medicaid programs.
Firm looks to bulk up on fat-reduction results
Wellness company On Target Health LLC, which one year ago launched a program to help overweight workers lose fat but not muscle, is seeing strong results from its first two clients.
British court ruling backs patent protecting Lilly’s Alimta
Eli Lilly and Co. received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.
Lilly facing first trials over Cymbalta withdrawal symptoms
Eli Lilly and Co. has been ordered to face claims it misled consumers about “brain zaps” and other withdrawal side effects tied to its antidepressant Cymbalta in the first cases slated to be heard by juries.
Zimmer, Biomet complete $13.35 billion merger
The Indiana-based company has taken the name Zimmer Biomet Holdings Inc. and will trade under the ticker symbol to "ZBH" on Monday. Zimmer Holdings Inc. agreed to buy privately-held Biomet in April 2014.
Lilly drug regimen costing $9,200 a month scores zero in study
In a new scoring system for oncology drugs, a leading group of U.S. cancer doctors awarded a zero for overall benefit to a regimen featuring Alimta, Eli Lilly and Co.’s top-selling product.
Lilly buoyed by string of positive results from drug trials
After years of pipeline failures, Eli Lilly and Co. is on a bit of a hot streak. This month alone, the Indianapolis-based drugmaker has reported positive results from clinical trials of four experimental drugs.
Cook Group President Hawkins plans retirement
Kem Hawkins, who has been president of Cook Group Inc. since 2001, will retire on July 1. He will be replaced by Pete Yonkman, who since 2013 has been president of Cook Medical, the Cook subsidiary that makes medical devices.
Report: Anthem makes $45B takeover bid for Cigna
Anthem Inc. has made a buyout offer to rival health insurer Cigna Corp. for $45 billion, The Wall Street Journal reported Monday. That price would make the deal the largest health insurance merger in U.S. history.
Startup aims to upend diabetes care with matchstick-size implant
Intarcia Therapeutics Inc. is betting its matchstick-size pump could take market share from Eli Lilly and Co., AstraZeneca Plc and Novo Nordisk A/S.
Walgreens, insurers push expansion of virtual doctor visits
Millions of people will be able to see a doctor on their smartphones or laptops for everyday ailments once the nation's largest drugstore chain and two major insurers expand a budding push into virtual health care.